Search results
Merck to Acquire EyeBio
Morningstar· 17 hours agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today announced that the ...
NYC Health Dept. to rely on donations for research journals amid budget cuts
Medical Xpress· 16 hours agoNew York City's top health officials will have access to fewer than two dozen medical research...
Urine Test Could Prevent Unnecessary Prostate Biopsies
Medscape· 6 days agoProstate cancer screening tests lack specificity in detecting higher-grade tumors, but a new urine...
Lung Cancer Screening IDs Pulmonary Comorbidities
Medscape· 7 days agoA majority of individuals with no reported history of COPD showed evidence of COPD symptoms.
New Expert Guidance on Assessing, Managing Spasticity
Medscape· 23 hours agoA new consensus guideline on the assessment and management of spasticity has been released. The...
Public hearings start for Certificate of Need application for potential surgery and medical...
WBRC Fox 6 Birmingham· 1 day agoThe Hoover Health Care Authority filed an application with the State Health Planning and Development...
Does EMTALA Apply to Pregnancy, Abortion? Ethicist Says Yes
Medscape· 2 days agoEthicist Art Caplan discusses abortion and the Emergency Medical Treatment and Labor Act (EMTALA).
Jump Financial LLC Decreases Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
ETF DAILY NEWS· 3 days agoJump Financial LLC trimmed its position in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 12.2% during the fourth quarter, according to the company in ...
Triamcinolone Offers Relief in Thyroid Eye Disease
Medscape· 23 hours agoPercutaneous injection of triamcinolone improved margin reflex distance 1 and upper eyelid retraction in patients with thyroid eye disease.
11,462 Shares in Inari Medical, Inc. (NASDAQ:NARI) Purchased by Dynamic Technology Lab Private Ltd
ETF DAILY NEWS· 7 days agoDynamic Technology Lab Private Ltd bought a new position in Inari Medical, Inc. (NASDAQ:NARI – Free Report) during the 4th quarter, according to its most recent Form 13F filing ...